Showing results (81-90 of 191) with videos related to
Sort By:
Pageof 20
Elife|December 16, 2014
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemiaJiguang Wang, Hossein Khiabanian, Davide Rossi, et al.Clinical and Experimental Rheumatology|February 22, 2018
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label studyCesare Mazzaro, Luigino Dal Maso, Luca Quartuccio, et al.Cytometry. Part B, Clinical Cytometry|August 15, 2006
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutationsAntonella Zucchetto, Riccardo Bomben, Michele Dal Bo, et al.The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumorsAngela V D'Elia, Gianluca Tell, Diego Russo, et al.International Journal of Molecular Sciences|April 3, 2019
Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial CellsChiara Agostinis, Elisa Masat, Fleur Bossi, et al.Proceedings of the National Academy of Sciences of the United States of America|October 30, 2015
p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stabilityLinda Fabris, Stefania Berton, Ilenia Pellizzari, et al.Cells|January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?Paola Menichini, Paola Monti, Andrea Speciale, et al.Frontiers in Oncology|June 23, 2022
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular InsightsChiara Salvetti, Candida Vitale, Valentina Griggio, et al.Journal of Cellular Physiology|December 7, 2005
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemiaAntonella Zucchetto, Riccardo Bomben, Michele Dal Bo, et al.Cancer|November 14, 2007
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, et al.Pageof 20